Hepatitis C is a common infection with
variable course that can lead to chronic
hepatitis, cirrhosis, and hepatocellular
carcinoma. The course of illness may be
adversely affected by various factors,
especially alcohol consumption. Therefore,
more than one drink per day is strongly
discouraged in patients with hepatitis C,
and abstinence from alcohol is
recommended. Initial therapy with
interferon alfa (or equivalent) should be
3 million units three times per week for
12 months. Patients not responding to
therapy after 3 months should not receive
further treatment with interferon alone,
but should be considered for combination
therapy of interferon and ribavirin or for
enrollment in investigational studies.
Individuals infected with the hepatitis C
virus should not donate blood, organs,
tissues, or semen. Safe sexual practices,
including the use of latex condoms, is
strongly encouraged for individuals with
multiple sexual partners. Expansion of
needle exchange programs should be
considered in an effort to reduce the rate
of transmission of hepatitis C among
injection drug users.
Read
full NIH Consensus Statement
Download
full NIH Consensus Statement (PDF
file, 352K)
Declaración
de Consenso del NIH en Español
(PDF file, 160K)
|